Agenus | AGEN - EPS Earnings Per Share


Agenus reported $1.02 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 1.02 -0.650 -1.03 May/11
FY2025Q4 Dec/2025 -0.3 -0.270 -2.04 Mar/16
FY2025Q3 Sep/2025 1.94 -0.280 -3.08 Nov/10
FY2025Q2 Jun/2025 -1.0 -0.270 -2.52 Aug/11
Mar/2025 -1.03 -0.260 May/12




Eps Change Date
AbbVie USD 3.65 1 Jun/2026
Agenus USD 1.02 1.32 Mar/2026
Amgen USD 6.29 1.14 Jun/2026
AstraZeneca USD 2.63 0.05 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Celldex Therapeutics USD -0.94 0.24 Jun/2026
CSL USD 5.07 3 Dec/2025
Eli Lilly USD 8.38 0.17 Jun/2026
Gilead Sciences USD -6.75 8.78 Jun/2026
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
Glaxosmithkline GBP 0.62 0.41 Mar/2026
Incyte USD 3.09 1.28 Jun/2026
Intrexon USD -0.1 0.03 Jun/2024
J&J USD 2.7 0.2 Sep/2026
Jiangsu Hengrui CNY 0.39 0.05 Jun/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
MacroGenics USD -0.58 0.36 Mar/2026
Merck EUR -0.54 2.65 Jun/2026
Merck USD -0.13 1.15 Jun/2026
Northwest Biotherapeutics USD -0.01 0 Mar/2026
Novartis USD 2.41 0.42 Jun/2026
Novavax USD 0.13 0.59 Dec/2025
Pfizer USD 0.77 0.02 Jun/2026
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Veracyte USD 0.54 0.02 Jun/2026